Literature DB >> 24769637

Time course for measuring endolymphatic size in healthy volunteers following intravenous administration of gadoteridol.

Shinji Naganawa1, Kojiro Suzuki, Masahiro Yamazaki, Yasuo Sakurai, Mitsuru Ikeda.   

Abstract

PURPOSE: We developed semi-quantitative methods to measure endolymphatic size on images obtained 4 hours after intravenous administration of single-dose gadolinium-based contrast medium (IV-SD-GBCM) and found little variation in results between observers. We used the methods to measure the size of the endolymph in healthy volunteers at various times after IV-SD-GBCM and attempted to determine the optimal timing for the evaluation.
METHODS: In 8 healthy male volunteers, we obtained heavily T2-weighted 3-dimensional fluid-attenuated inversion recovery (hT2W-3D-FLAIR) images 1.5, 3, 4.5, and 6 hours after IV-SD-GBCM as positive perilymph images (PPI) as well as acquiring positive endolymph images (PEI) and magnetic resonance cisternography (MRC). To evaluate the endolymph, we generated 2 kinds of processed images (HYDROPS-Mi2 and HYDROPS2-Mi2) by subtracting PEI or MRC from PPI as previously proposed. We semi-quantitatively measured the ratio of the area of the endolymph (%EL) to that of total lymph on the 2 kinds of generated images for the cochlea and vestibule according to the previously proposed method. We analyzed statistics to evaluate the change in %EL over time and used analysis of variance (ANOVA) for a 2 × 4 repeated-measures design to assess difference in image type. We adopted 5% as a significance level.
RESULTS: The %EL was significantly larger at 1.5 hours after IV-SD-GBCM than at 3, 4.5, and 6 hours in both the cochlea and vestibule for both kinds of generated images. Between 4.5 and 6 hours, the %EL plateaued for both the cochlea and vestibule, and the 2 kinds of generated images did not differ significantly.
CONCLUSION: A delay of 1.5 hours after IV-SD-GBCM is not sufficient to evaluate endolymphatic size. The %EL plateaus between 4.5 and 6 hours. These data might be valuable for further clinical studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24769637     DOI: 10.2463/mrms.2013-0080

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  12 in total

Review 1.  Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance.

Authors:  Shinji Naganawa; Tsutomu Nakashima
Journal:  Jpn J Radiol       Date:  2014-02-06       Impact factor: 2.374

2.  Recurrent peripheral vestibulopathy: Is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice?

Authors:  Arnaud Attyé; G Dumas; I Troprès; M Roustit; A Karkas; E Banciu; J Pietras; L Lamalle; S Schmerber; A Krainik
Journal:  Eur Radiol       Date:  2015-03-28       Impact factor: 5.315

Review 3.  Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

Authors:  Rita Sousa; Francisco Raposo; Carla Guerreiro; David Berhanu; Tiago Eça; J Campos; Leonel Luís
Journal:  Neuroradiology       Date:  2021-06-17       Impact factor: 2.804

4.  Improved HYDROPS: Imaging of Endolymphatic Hydrops after Intravenous Administration of Gadolinium.

Authors:  Shinji Naganawa; Hisashi Kawai; Toshiaki Taoka; Michihiko Sone
Journal:  Magn Reson Med Sci       Date:  2017-05-22       Impact factor: 2.471

5.  Quantification of Endolymphatic Space Volume after Intravenous Administration of a Single Dose of Gadolinium-based Contrast Agent: 3D-real Inversion Recovery versus HYDROPS-Mi2.

Authors:  Toshio Ohashi; Shinji Naganawa; Ai Takeuchi; Toshio Katagiri; Kayao Kuno
Journal:  Magn Reson Med Sci       Date:  2019-05-07       Impact factor: 2.471

Review 6.  Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review.

Authors:  Marlène Rasschaert; Roy O Weller; Josef A Schroeder; Christoph Brochhausen; Jean-Marc Idée
Journal:  J Magn Reson Imaging       Date:  2020-04-04       Impact factor: 4.813

7.  VOLT: a novel open-source pipeline for automatic segmentation of endolymphatic space in inner ear MRI.

Authors:  J Gerb; S A Ahmadi; E Kierig; B Ertl-Wagner; M Dieterich; V Kirsch
Journal:  J Neurol       Date:  2020-07-14       Impact factor: 4.849

8.  Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.

Authors:  Xavier Violas; Marlène Rasschaert; Robin Santus; Cécile Factor; Claire Corot; Sarah Catoen; Jean-Marc Idée; Philippe Robert
Journal:  Invest Radiol       Date:  2022-02-01       Impact factor: 6.016

9.  Heavily T₂-Weighted 3D-FLAIR Improves the Detection of Cochlear Lymph Fluid Signal Abnormalities in Patients with Sudden Sensorineural Hearing Loss.

Authors:  Shinji Naganawa; Hisashi Kawai; Toshiaki Taoka; Kojiro Suzuki; Shingo Iwano; Hiroko Satake; Michihiko Sone; Mitsuru Ikeda
Journal:  Magn Reson Med Sci       Date:  2015-11-20       Impact factor: 2.471

10.  Cochlear Lymph Fluid Signal Increase in Patients with Otosclerosis after Intravenous Administration of Gadodiamide.

Authors:  Shinji Naganawa; Hisashi Kawai; Toshiaki Taoka; Kojiro Suzuki; Shingo Iwano; Hiroko Satake; Michihiko Sone; Mitsuru Ikeda
Journal:  Magn Reson Med Sci       Date:  2016-02-03       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.